Preimplantation Genetic Testing for Aneuploidy in Patients of Different Age: a Systematic Review and Meta-analysis

Overview

Journal Obstet Gynecol Sci

Specialty Gynecology & Obstetrics

Date 2024 May 28

PMID 38803301

Authors

Leila Adamyan

Laura Pivazyan

Lilia Obosyan

Ekaterina Krylova

Sapiyat Isaeva

Affiliations

Soon will be listed here.

Abstract

This study aimed to summarize the current knowledge on the benefits of in vitro fertilization/intracytoplasmic sperm injection with preimplantation genetic testing for aneuploidy (PGT-A) and to discuss the role of PGT-A in patients of different ages undergoing assisted reproduction. A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 checklist. Registration number: CRD42022354697. Studies were identified by searching the PubMed, Cochrane Library, Google Scholar, Scopus, Embase, and ClinicalTrials databases. Seven meta-analyses were performed with additional stratification of age and prognosis of the women studied. Clinical pregnancy rate per embryo transfer in patients aged >35 years was higher in the PGT-A group (P=0.0002) than in controls. Live birth rate (LBR) per embryo transfer in women 35 years old or younger (P=0.002) was higher in the PGT-A group. The LBR per patient in women aged >35 years was higher in the PGT-A group (P=0.004). The effects of PGT-A on LBR in patients with poor prognosis showed a statistically significant increase (P=0.003). There was no significant difference in the rate between the two groups. PGT-A is effective and can be recommended for patients aged >35 years undergoing assisted reproduction to improve their reproductive outcomes. Moreover, our study showed the possible benefits of PGT-A in patients with a poor prognosis. Overall, our findings suggest that PGT-A is a valuable tool for improving the reproductive outcomes of assisted reproductive procedures in older women and those with a history of pregnancy complications.

References

Ozgur K, Berkkanoglu M, Bulut H, Yoruk G, Candurmaz N, Coetzee K . Single best euploid versus single best unknown-ploidy blastocyst frozen embryo transfers: a randomized controlled trial. J Assist Reprod Genet. 2019; 36(4):629-636. PMC: 6505013. DOI: 10.1007/s10815-018-01399-1. View

Yang Z, Liu J, Collins G, Salem S, Liu X, Lyle S . Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet. 2012; 5(1):24. PMC: 3403960. DOI: 10.1186/1755-8166-5-24. View

Schoolcraft W, Katz-Jaffe M, Stevens J, Rawlins M, Munne S . Preimplantation aneuploidy testing for infertile patients of advanced maternal age: a randomized prospective trial. Fertil Steril. 2008; 92(1):157-62. DOI: 10.1016/j.fertnstert.2008.05.029. View

Pirtea P, de Ziegler D, Tao X, Sun L, Zhan Y, Ayoubi J . Rate of true recurrent implantation failure is low: results of three successive frozen euploid single embryo transfers. Fertil Steril. 2020; 115(1):45-53. DOI: 10.1016/j.fertnstert.2020.07.002. View

Gleicher N, Albertini D, Barad D, Homer H, Modi D, Murtinger M . The 2019 PGDIS position statement on transfer of mosaic embryos within a context of new information on PGT-A. Reprod Biol Endocrinol. 2020; 18(1):57. PMC: 7257212. DOI: 10.1186/s12958-020-00616-w. View

Del Carmen Nogales M, Cruz M, de Frutos S, Martinez E, Gaytan M, Ariza M . Association between clinical and IVF laboratory parameters and miscarriage after single euploid embryo transfers. Reprod Biol Endocrinol. 2021; 19(1):186. PMC: 8670289. DOI: 10.1186/s12958-021-00870-6. View

Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar J, Verhoeve H . In vitro fertilization with preimplantation genetic screening. N Engl J Med. 2007; 357(1):9-17. DOI: 10.1056/NEJMoa067744. View

Munne S, Sandalinas M, Escudero T, Marquez C, Cohen J . Chromosome mosaicism in cleavage-stage human embryos: evidence of a maternal age effect. Reprod Biomed Online. 2003; 4(3):223-32. DOI: 10.1016/s1472-6483(10)61810-x. View

Friedenthal J, Maxwell S, Munne S, Kramer Y, McCulloh D, McCaffrey C . Next generation sequencing for preimplantation genetic screening improves pregnancy outcomes compared with array comparative genomic hybridization in single thawed euploid embryo transfer cycles. Fertil Steril. 2018; 109(4):627-632. DOI: 10.1016/j.fertnstert.2017.12.017. View

10.

Gorodeckaja J, Neumann S, McCollin A, Ottolini C, Wang J, Ahuja K . High implantation and clinical pregnancy rates with single vitrified-warmed blastocyst transfer and optional aneuploidy testing for all patients. Hum Fertil (Camb). 2019; 23(4):256-267. DOI: 10.1080/14647273.2018.1551628. View

11.

Vinals Gonzalez X, Odia R, Naja R, Serhal P, Saab W, Seshadri S . Euploid blastocysts implant irrespective of their morphology after NGS-(PGT-A) testing in advanced maternal age patients. J Assist Reprod Genet. 2019; 36(8):1623-1629. PMC: 6707991. DOI: 10.1007/s10815-019-01496-9. View

12.

Mersereau J, Pergament E, Zhang X, Milad M . Preimplantation genetic screening to improve in vitro fertilization pregnancy rates: a prospective randomized controlled trial. Fertil Steril. 2007; 90(4):1287-9. DOI: 10.1016/j.fertnstert.2007.08.010. View

13.

Zegers-Hochschild F, Adamson G, Dyer S, Racowsky C, de Mouzon J, Sokol R . The International Glossary on Infertility and Fertility Care, 2017. Fertil Steril. 2017; 108(3):393-406. DOI: 10.1016/j.fertnstert.2017.06.005. View

14.

Franasiak J, Forman E, Hong K, Werner M, Upham K, Treff N . The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2013; 101(3):656-663.e1. DOI: 10.1016/j.fertnstert.2013.11.004. View

15.

Sarkar P, New E, Jindal S, Tanner J, Imudia A . The effect of trophectoderm biopsy for preimplantation genetic testing on fetal birth weight and preterm delivery. Minerva Obstet Gynecol. 2023; 76(4):327-334. DOI: 10.23736/S2724-606X.22.05196-X. View

16.

Sato T, Sugiura-Ogasawara M, Ozawa F, Yamamoto T, Kato T, Kurahashi H . Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure. Hum Reprod. 2019; 34(12):2340-2348. DOI: 10.1093/humrep/dez229. View

17.

Somigliana E, Busnelli A, Paffoni A, Vigano P, Riccaboni A, Rubio C . Cost-effectiveness of preimplantation genetic testing for aneuploidies. Fertil Steril. 2019; 111(6):1169-1176. DOI: 10.1016/j.fertnstert.2019.01.025. View

18.

Jansen R, Bowman M, de Boer K, Leigh D, Lieberman D, McArthur S . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Hum Reprod. 2008; 23(7):1476-8. DOI: 10.1093/humrep/den129. View

19.

Liu Y, Yu T, Wang P, Tzeng C, Chen C, Chen C . Could PGT-A pick up true abnormalities that have clinical relevance? Retrospective analysis of 1043 embryos. Taiwan J Obstet Gynecol. 2020; 59(4):496-501. DOI: 10.1016/j.tjog.2020.05.005. View

20.

Baart E, Van Opstal D, Los F, Fauser B, Martini E . Fluorescence in situ hybridization analysis of two blastomeres from day 3 frozen-thawed embryos followed by analysis of the remaining embryo on day 5. Hum Reprod. 2004; 19(3):685-93. DOI: 10.1093/humrep/deh094. View